NIAID Funding Opportunity: Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention

National Institute of Allergy and Infectious Diseases sent this bulletin at 05/31/2022 12:21 PM EDT

Having trouble viewing this email? View it as a Web page.

Funding Opportunity

RFA-AI-22-038, A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01, Clinical Trial Not Allowed)

For more, check NIAID Opportunities and Announcements.

You can follow us on Twitter: @NIAIDFunding.

National Institute of Allergy and Infectious Diseases | National Institutes of Health

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help.

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).